Cargando…

Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study

SIMPLE SUMMARY: This study provides physicians’ perspectives on the information cancer patients with autoimmune diseases should learn when considering ICI. This information can be incorporated into patient–doctor discussions and educational tools to improve shared decision-making in this patient pop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Olivo, Maria A., Duhon, Gabrielle F., Ruiz, Juan I., Altan, Mehmet, Tawbi, Hussein, Diab, Adi, Bingham, Clifton O., Calabrese, Cassandra, Heredia, Natalia I., Volk, Robert J., Suarez-Almazor, Maria E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216836/ https://www.ncbi.nlm.nih.gov/pubmed/37345026 http://dx.doi.org/10.3390/cancers15102690

Ejemplares similares

Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors
por: Lopez-Olivo, Maria A., et al.
Publicado: (2023)

COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review
por: Ruiz, Juan I., et al.
Publicado: (2023)

COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
por: Ruiz, Juan Ignacio, et al.
Publicado: (2023)

Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan
por: Ruiz, Juan Ignacio, et al.
Publicado: (2022)

The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy
por: Bruera, Sebastian, et al.
Publicado: (2022)

Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis
por: Lopez-Olivo, Maria A., et al.
Publicado: (2022)

A Randomized Controlled Trial Comparing Two Self‐Administered Educational Strategies for Patients With Knee Osteoarthritis
por: Lopez‐Olivo, Maria A., et al.
Publicado: (2021)

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
por: Riveiro-Barciela, Mar, et al.
Publicado: (2023)

Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
por: Abdel-Wahab, Noha, et al.
Publicado: (2016)

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
por: Qureshi, Sehrish, et al.
Publicado: (2023)

A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis
por: Lopez-Olivo, Maria A., et al.
Publicado: (2022)

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
por: Safa, Houssein, et al.
Publicado: (2019)

The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
por: Kreidieh, Firas Y., et al.
Publicado: (2023)

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
por: Mamlouk, Omar, et al.
Publicado: (2019)

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
por: Kim, Sang T., et al.
Publicado: (2022)

Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis
por: Pan, Xin, et al.
Publicado: (2017)

Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies
por: des Bordes, Jude, et al.
Publicado: (2020)

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
por: Maeda, Osamu
Publicado: (2023)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
por: Puzanov, I., et al.
Publicado: (2017)

A comprehensive scoping review to identify standards for the development of health information resources on the internet
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare
por: Kim, Sang T., et al.
Publicado: (2019)

Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases
por: Aguilar-Company, Juan, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps
por: Cappelli, Laura C., et al.
Publicado: (2020)

Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series
por: Albayda, Jemima, et al.
Publicado: (2019)

Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease
por: Alexander, Swetha, et al.
Publicado: (2021)

Psychosocial Determinants of Total Knee Arthroplasty Outcomes Two Years After Surgery
por: Lopez‐Olivo, Maria A., et al.
Publicado: (2020)

Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer
por: Suarez-Almazor, Maria E., et al.
Publicado: (2022)

Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis
por: Karpes Matusevich, Aliza R, et al.
Publicado: (2021)

Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time
por: Cappelli, Laura C., et al.
Publicado: (2021)

Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
por: Calabrese, Cassandra, et al.
Publicado: (2019)

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies
por: Atkins, Michael B, et al.
Publicado: (2023)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Proposal to negotiate an extension of the existing contract for the provision of actuarial services to the CERN Pension Fund
Publicado: (2015)

Proposal to negotiate an amendment to an existing contract for the provision of actuarial services to the CERN Pension Fund
Publicado: (2014)

Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series
por: Holbrook, Kourtney, et al.
Publicado: (2019)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Targeted therapy in melanoma
por: Tawbi, Hussein, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sfd89e6ubljjlcgk691jl0hplc